Avita Medical (ASX:AVH) reported Friday a second-quarter loss of $0.38 per share, compared with $0.6 a year earlier.

Analysts polled by Visible Alpha expected a loss of $0.27.

Revenue for the quarter ended June 30 was $18.4 million, compared with $15.2 million a year earlier.

Analysts surveyed by Visible Alpha expected $21.8 million.

The company lowered its full-year 2025 revenue guidance to a range of $76 million to $81 million, from $100 million to $106 million, reflecting growth of 19% to 27% from the prior year.